Survey of off-label anti-IL1 treatments in France: preliminary data

Survey of off-label anti-IL1 treatments in France: preliminary data

Bibliographic Details
Main Authors:	Koné-Paut I, Fautrel B, Galeotti C, Rossi-Semerano L
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Editorial: Pathogenesis, Clinical Findings, and Treatment Advances in Kawasaki Disease
by: Teresa Giani, et al.
Published: (2021-10-01)

Health-related quality of life in children with PFAPA syndrome
by: Claire Grimwood, et al.
Published: (2018-08-01)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
by: Koné-Paut I, et al.
Published: (2011-09-01)

Hypofertility in Muckle Wells syndrome and treatment with IL-1 targeting drugs
by: Tran Tu-Anh, et al.
Published: (2011-09-01)

Off-label dermatologic uses of IL-17 inhibitors
by: Kevin K. Wu, et al.
Published: (2022-01-01)

The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases
by: Oded Shamriz, et al.
Published: (2021-04-01)

The knowledge and experience with the off-label use – results of a survey
by: Maria Drenska, et al.
Published: (2019-12-01)

Subcutaneous anakinra in the management of refractory MIS-C in France
by: Perrine Dusser, et al.
Published: (2024-02-01)

Trends in utilization and off-label use of polyethylene glycol 4000 laxatives and the prevalence of constipation in children in France
by: Qizilbash N, et al.
Published: (2011-07-01)

OFF-LABEL PRESCRIBING OF ANTIPSYCHOTICS – A QUESTIONNAIRE SURVEY OF FINNISH PHYSICIANS
by: Jami Pentinlehto, et al.
Published: (2021-11-01)

Off-label use of rituximab in dermatology: pemphigus treatment
by: Lislaine Bomm, et al.
Published: (2013-08-01)

Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to School
by: Baptiste Quéré, et al.
Published: (2021-11-01)

Still’s Disease in the Constellation of Hyperinflammatory Syndromes: A Link with Kawasaki Disease?
by: Perrine Dusser, et al.
Published: (2021-07-01)

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease
by: Isabelle Koné-Paut, et al.
Published: (2022-11-01)

The problem of off label drug use in pediatrics: pediatricians and parents survey results
by: E. A. Mardganieva, et al.
Published: (2018-05-01)

Preliminary squid survey in coastal waters off Kuala Terengganu, Malaysia
by: Shahardin, Zainal Ashirin, et al.
Published: (1992)

Off-label medications in the treatment of hospitalized children with atopic dermatitis
by: Michał Niedźwiedź, et al.
Published: (2022-10-01)

Early off-label treatment during pandemics? A dilemma
by: Jan A. Roth, et al.
Published: (2020-05-01)

Il ruolo dell'infermiere in ambulatorio di nefrologia
by: P. Galeotti
Published: (2018-01-01)

Off-label drug in the newborn
by: Laura Cuzzolin
Published: (2014-10-01)

Off-label Utilization of Antidepressants
by: Daniele Fabio Zullino, et al.
Published: (2008-01-01)

A Survey of Off-label and Unlicensed Antibiotic and Respiratory Medications Prescribed for Toddler Patients
by: Ali Soochi, et al.
Published: (2022-12-01)

An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide
by: Newton Phillip J, et al.
Published: (2012-04-01)

Analysis of primary outpatient data for off-label use of medicines in neurology
by: Maria Drenska, et al.
Published: (2019-12-01)

Preliminary Data from Six Years of Selective Anthelmintic Treatment on Five Horse Farms in France and Switzerland
by: Liselore Roelfstra, et al.
Published: (2020-12-01)

Comparison of canine owner profile according to food choice: an online preliminary survey in France
by: S. Hoummady, et al.
Published: (2022-05-01)

Massive presence of off‐label medicines in Danish neonatal departments: A nationwide survey using national hospital purchase data
by: Christina Gade, et al.
Published: (2023-02-01)

Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis
by: Federico Silvestri, et al.
Published: (2015-10-01)

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
by: Zhiyu Zhang, et al.
Published: (2023-06-01)

PRESCRIÇÃO DE MEDICAMENTOS OFF-LABEL
by: Ana Escoval, et al.
Published: (2011-09-01)

The journey of canakinumab; on- and off-label indications
by: Daniela Marotto, et al.
Published: (2019-05-01)

Prescripción off-label de medicamentos
by: Laura Bierzychudek
Published: (2022-06-01)

Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01)

Off-label drugs for weight management
by: Hendricks EJ
Published: (2017-06-01)

Off-label uses of retinoids in dermatology
by: Wei Li, et al.
Published: (2012-09-01)

Off-label uses of etanercept in dermatology
by: Andrés Tirado-Sánchez, et al.
Published: (2016-01-01)

Off-label promotion, on-target sales.
by: Adriane Fugh-Berman, et al.
Published: (2008-10-01)

Off-label and unlicensed drugs in neonatology
by: Segundo Rite-Gracia, et al.
Published: (2021-03-01)

Off-label prescriptions in diabetic foot
by: Luís Jesuíno de Oliveira Andrade, et al.
Published: (2014-09-01)

Off-label pediatric medicines in Spain
by: Roi Piñeiro Pérez, et al.
Published: (2021-03-01)